Musaffa's Global Halal Trading Platform is Here!
Start Investing NowALNY Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: November 03, 2025
Report Source: 2025 3rd Quarter Report
Alnylam Pharmaceuticals Inc. Stock Analysis ALNY
United States Health Care Large Cap Report: Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Cambridge, Massachusetts and currently employs 2,230 full-time employees. The company went IPO on 2004-05-28. The firm is engaged in discovering, developing, manufacturing and commercializing novel therapeutics based on ribonucleic acid interference (RNAi). Its marketed products include AMVUTTRA (vutrisiran) for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR) with polyneuropathy in adults; ONPATTRO (patisiran) for the treatment of the polyneuropathy of hATTR amyloidosis in adults; GIVLAARI (givosiran) for the treatment of adults with acute hepatic porphyria; OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1, and Leqvio (inclisiran), which is being developed and commercialized by its partner, Novartis AG, for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. The Company’s clinical development programs include Cemdisiran, Fitusiran, Zilebesiran, Elebsiran, Mivelsiran and ALN-HTT02. The company is developing Cemdisiran to treat complement-mediated diseases.
Read More Alnylam Pharmaceuticals Inc (ALNY) Chart
Alnylam Pharmaceuticals Inc (ALNY) vs CBOE Volatility Index (VIX) Comparative Returns
Analysis of Alnylam Pharmaceuticals Inc (ALNY) stock performance compared to the broader market (CBOE Volatility Index (VIX)) across multiple timeframes.
YTD Performance
- Alnylam Pharmac... (ALN...) -22.42%
- CBOE Volatility Index (VIX) 7.42%
Alnylam Pharmac... Underperformed CBOE Volatility Index (VIX) by 29.84%
1Y Performance
- Alnylam Pharmac... (ALN...) 15.99%
- CBOE Volatility Index (VIX) -3.02%
Alnylam Pharmac... Outperformed CBOE Volatility Index (VIX) by 19.01%
3Y Performance
- Alnylam Pharmac... (ALN...) 38.74%
- CBOE Volatility Index (VIX) -19.46%
Alnylam Pharmac... Outperformed CBOE Volatility Index (VIX) by 58.20%
5Y Performance
- Alnylam Pharmac... (ALN...) 95.34%
- CBOE Volatility Index (VIX) -51.47%
Alnylam Pharmac... Outperformed CBOE Volatility Index (VIX) by 146.81%
Key Statistics of Alnylam Pharmaceuticals Inc (ALNY)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$314.42Volume
2.90MP/E Ratio (TTM)
-52 Week Range
Market Cap
44.66BAvg. Volume
1.64MDividend Yield
-Financial Metrics & Statements of Alnylam Pharmaceuticals Inc (ALNY)
Super Investors Invested in Alnylam Pharmaceuticals Inc (ALNY)
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Dodge & Cox
% Portfolio:
0.52 Recent Activity:-5.32%
George Soros
% Portfolio:
0.29 Recent Activity:100.00%
Jefferies Group
% Portfolio:
0.07 Recent Activity:98.30%
Joel Greenblatt
% Portfolio:
0.06 Recent Activity:58.18%
Community-Curated Collections with Alnylam Pharmaceuticals Inc (ALNY) ( With ALNY )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
FAQ's for Alnylam Pharmaceuticals Inc (ALNY)
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Related Halal Stocks to Alnylam Pharmaceuticals Inc (ALNY)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
